3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma
3
Ovarian Neoplasms
2
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Osteosarcoma
1
Fanconi Anemia, Complementation Group D1
1
Chondrosarcoma
1
Bone Neoplasms
1
Interventions
Cyclophosphamide
3
seclidemstat
2
Topotecan
2
Drug Therapy
2
irinotecan sucrosofate
1
anlotinib
1
Vinorelbine
1
Vincristine
1
Triptorelin Pamoate
1
Trabectedin
1
Temozolomide
1
TQ-B3525
1
Microbiota
1
Metabolome
1
Irinotecan
1
IVA protocol
1
Biological Factors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Sarcoma, Ewing
×
Trabectedin
×
Clear all
NCT05131386
2023-03-27
SYNERGIAS
Grupo Espanol de Investigacion en Sarcomas
Phase 2
Unknown
85 enrolled